ATYR PHARMA INC(ATYR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ATYR ATYR PHARMA INC

交易中 09-10 15:09:43 EDT

0.4325

-0.0229

-5.03%

最高0.4694	最低0.4301	成交量71.13万
今开0.4690	昨收0.4554	日振幅8.63%
总市值4,238万	流通市值4,151万	总股本9,799万
成交额31.79万	换手率0.74%	流通股本9,597万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ATYR","market":"US","secType":"STK","nameCN":"ATYR PHARMA INC","latestPrice":0.4325,"timestamp":1789067376700,"preClose":0.4554,"halted":0,"volume":711347,"delay":0,"changeRate":-0.050285463328941654,"floatShares":95966000,"shares":97986634,"eps":-0.621383,"marketStatus":"交易中","change":-0.0229,"latestTime":"09-10 15:09:43 EDT","open":0.469,"high":0.4694,"low":0.4301,"amount":317888.04912501,"amplitude":0.086298,"askPrice":0.4399,"askSize":700,"bidPrice":0.4314,"bidSize":388,"shortable":3,"etf":0,"ttmEps":-0.621383,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":0,"listingDate":1430971200000,"exchange":"NASDAQ","adjPreClose":0.4554,"preHourTrading":{"tag":"盘前","latestPrice":0.46,"preClose":0.4554,"latestTime":"09:29 EDT","volume":6288,"amount":2942.2678809599997,"timestamp":1789046999075,"change":0.0046,"changeRate":0.010101,"amplitude":0.059728},"postHourTrading":{"tag":"盘后","latestPrice":0.46,"preClose":0.4554,"latestTime":"19:30 EDT","volume":3908,"amount":1796.8846,"timestamp":1788996606331,"change":0.0046,"changeRate":0.010101,"amplitude":0.022617},"volumeRatio":1.455387,"impliedVol":2.372,"impliedVolPercentile":0.7809},"requestUrl":"/m/hq/s/ATYR","defaultTab":"news","newsList":[{"id":"1139567683","title":"aTyr Pharma更新计划中Efzofitimod治疗肺结节病III期研究的监管反馈时间表","url":"https://stock-news.laohu8.com/highlight/detail?id=1139567683","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139567683?lang=zh_cn&edition=full","pubTime":"2026-09-02 04:37","pubTimestamp":1788295071,"startTime":"0","endTime":"0","summary":"aTyr Pharma日前就其在研药物Efzofitimod（用于治疗肺结节病）所计划的III期临床研究的监管反馈时间，对外发布了最新动态。此次更新为公司的研发进程提供了新的时间参考框架，并明确了接下来与监管机构沟通的关键节点。公司方面表示，目前正就该项研究的方案设计与相关监管当局保持沟通，并期待在既定时间表内获得进一步指引。该更新公告旨在向投资者及业界同步最新进展，以体现公司在推进这一潜在治疗方案上的持续努力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATYR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106699740","title":"人事变动，aTyr Pharma 财务总监更替，布兰登·亚拉斯接棒吉尔·布罗德富特","url":"https://stock-news.laohu8.com/highlight/detail?id=1106699740","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106699740?lang=zh_cn&edition=full","pubTime":"2026-08-08 04:02","pubTimestamp":1786132931,"startTime":"0","endTime":"0","summary":"aTyr Pharma 宣布，公司首席财务官吉尔·布罗德富特（Jill Broadfoot）即将卸任，而布兰登·亚拉斯（Brandon Yaras）将接替其职务，自2026年10月1日起生效。这标志着这家生物制药公司财务领导层迎来新的篇章。布罗德富特在任期间，为公司财务战略与运营稳定做出了重要贡献；如今，她选择功成身退。与此同时，继任者亚拉斯将肩负起引领公司财务规划及资本运作的重任。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATYR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126350045","title":"aTyr Pharma Inc 主要终点设定为第48周FVC变化；关键次要终点为KSQ-Lung评分较基线的变化","url":"https://stock-news.laohu8.com/highlight/detail?id=1126350045","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126350045?lang=zh_cn&edition=full","pubTime":"2026-05-12 04:04","pubTimestamp":1778529867,"startTime":"0","endTime":"0","summary":"aTyr Pharma Inc宣布，其临床试验的主要疗效终点将设定为第48周时用力肺活量（FVC）的变化情况。与此同时，研究的关键次要终点则确定为KSQ-Lung评分相对于基线的改变。这一设定明确了该生物制药公司后续临床数据评估的核心方向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATYR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177763181","title":"aTyr Pharma宣布：在下一项三期临床试验中，将5.0毫克/公斤Efzofitimod或安慰剂的给药频率提升至每三周一次","url":"https://stock-news.laohu8.com/highlight/detail?id=1177763181","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177763181?lang=zh_cn&edition=full","pubTime":"2026-05-12 04:04","pubTimestamp":1778529858,"startTime":"0","endTime":"0","summary":"生物制药公司aTyr Pharma Inc. 已公布其下一阶段三期临床试验方案的调整细节。核心变动在于，试验药物Efzofitimod（剂量为5.0毫克/公斤）及其对照安慰剂的给药频率，将从原有方案增加至每三周进行一次。这一调整旨在进一步评估该药物在延长给药间隔下的疗效与安全性表现，为后续的临床开发与潜在上市申请收集关键数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATYR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139871784","title":"ATYR PHARMA INC：将结合FDA反馈，继续推进Efzofitimod治疗肺结节病的研发进程","url":"https://stock-news.laohu8.com/highlight/detail?id=1139871784","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139871784?lang=zh_cn&edition=full","pubTime":"2026-05-12 04:02","pubTimestamp":1778529735,"startTime":"0","endTime":"0","summary":"ATYR PHARMA INC宣布，公司将依据美国食品药品监督管理局（FDA）提供的反馈意见，继续推进其候选药物Efzofitimod用于治疗肺结节病的临床开发计划。这一决定标志着公司在该适应症研发路径上的一个重要里程碑，表明其致力于遵循监管机构的科学指导，以优化后续临床试验的设计与执行。公司此举旨在更有效地评估该疗法的潜力，并为肺结节病患者带来新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATYR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518227987","title":"Atyr Pharma, Inc.盘中异动 大幅跳水5.15%报3.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518227987","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518227987?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:01","pubTimestamp":1741615271,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时01分，Atyr Pharma, Inc.股票出现波动，股价大幅跳水5.15%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为3125.10%、665.08%、307.84%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Impact Biomedical, Inc.，振幅分别为41.36%、40.24%、28.59%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022011196403dc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022011196403dc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517165552","title":"Atyr Pharma, Inc.盘中异动 早盘急速跳水5.40%报2.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517165552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517165552?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:35","pubTimestamp":1741271727,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时35分，Atyr Pharma, Inc.股票出现异动，股价大幅下跌5.40%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。其相关个股中，Plus Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Aeon Biopharma, Inc.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1013.38%、153.21%、52.21%，振幅较大的相关个股有Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为24.20%、23.83%、23.12%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223527963c4da0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223527963c4da0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517107739","title":"Atyr Pharma, Inc.盘中异动 早盘股价大涨5.28%报3.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517107739","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517107739?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:32","pubTimestamp":1741185126,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时32分，Atyr Pharma, Inc.股票出现波动，股价急速上涨5.28%。截至发稿，该股报3.19美元/股，成交量18.6199万股，换手率0.22%，振幅0.99%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223206989d4604&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223206989d4604&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516630867","title":"Atyr Pharma, Inc.盘中异动 早盘股价大跌5.44%报3.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516630867","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516630867?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:13","pubTimestamp":1741014780,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时13分，Atyr Pharma, Inc.股票出现波动，股价大幅下跌5.44%。截至发稿，该股报3.74美元/股，成交量17.4567万股，换手率0.21%，振幅6.19%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303231300abe640c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303231300abe640c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514470018","title":"Atyr Pharma, Inc.盘中异动 早盘股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514470018","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514470018?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:03","pubTimestamp":1740495794,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时03分，Atyr Pharma, Inc.股票出现异动，股价急速下挫5.22%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.05%。其相关个股中，Silexion Therapeutics Corp、Lava Therapeutics N.V.、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为997.49%、572.79%、502.27%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Nutriband Inc C/Wts ，振幅分别为46.65%、43.70%、42.76%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230314962ffa0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230314962ffa0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513727077","title":"Atyr Pharma, Inc.盘中异动 股价大跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727077","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513727077?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:51","pubTimestamp":1740408694,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时51分，Atyr Pharma, Inc.股票出现异动，股价急速跳水5.56%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为128.96%、54.25%、24.94%，振幅较大的相关个股有Pepgen Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Vaxart, Inc. - Common Stock，振幅分别为137.23%、41.14%、21.42%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225134abdb12cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225134abdb12cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513999022","title":"Atyr Pharma, Inc.盘中异动 早盘股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513999022","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513999022?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:00","pubTimestamp":1740150054,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时00分，Atyr Pharma, Inc.股票出现波动，股价急速拉升5.19%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Nkgen Biotech, Inc.、Omega Therapeutics, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、蓝鸟生物较为活跃，换手率分别为110.59%、90.12%、29.67%，振幅较大的相关个股有Osr Holdings Inc C/Wts 09/02/2028 、Omega Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为57.50%、35.45%、33.83%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221230054a24eb7c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221230054a24eb7c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512748821","title":"Atyr Pharma, Inc.盘中异动 急速上涨5.01%报3.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512748821","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512748821?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:31","pubTimestamp":1739975486,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时31分，Atyr Pharma, Inc.股票出现异动，股价大幅拉升5.01%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Osr Holdings, Inc.、Aditxt, Inc.、Citius Pharmaceuticals, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Chemomab Therapeutics Ltd较为活跃，换手率分别为205.66%、202.13%、65.55%，振幅较大的相关个股有Osr Holdings, Inc.、Azitra Inc、2Seventy Bio, Inc.，振幅分别为21.86%、11.29%、7.53%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223126988b3144&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223126988b3144&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512653971","title":"Atyr Pharma, Inc.盘中异动 早盘股价大涨5.22%报3.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512653971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512653971?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:31","pubTimestamp":1739889072,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时31分，Atyr Pharma, Inc.股票出现异动，股价大幅上涨5.22%。截至发稿，该股报3.59美元/股，成交量6.2845万股，换手率0.07%，振幅0.00%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223113a24aac55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223113a24aac55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511195406","title":"Atyr Pharma, Inc.盘中异动 下午盘快速跳水5.01%报3.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511195406","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511195406?lang=zh_cn&edition=full","pubTime":"2025-02-15 02:44","pubTimestamp":1739558642,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日02时44分，Atyr Pharma, Inc.股票出现波动，股价大幅下跌5.01%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Moleculin Biotech, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Allogene Therapeutics, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3011.57%、778.71%、611.12%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Moleculin Biotech, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为74.35%、71.65%、66.45%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502150244029885c33d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502150244029885c33d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510022899","title":"Atyr Pharma, Inc.盘中异动 急速跳水5.00%报3.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510022899","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510022899?lang=zh_cn&edition=full","pubTime":"2025-02-11 03:07","pubTimestamp":1739214477,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日03时07分，Atyr Pharma, Inc.股票出现波动，股价急速下跌5.00%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.79%。其相关个股中，Dominari Holdings Inc.、Springworks Therapeutics, Inc.、Nls Pharmaceutics Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为3115.84%、1664.97%、1394.79%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Biodexa Pharmaceuticals Plc、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为99.86%、89.68%、87.80%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502110307579880ad71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502110307579880ad71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508474450","title":"Atyr Pharma, Inc.盘中异动 快速上涨5.04%报3.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508474450","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508474450?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:54","pubTimestamp":1738680889,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时54分，Atyr Pharma, Inc.股票出现异动，股价急速上涨5.04%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。其相关个股中，Azitra Inc、Evaxion Biotech As、Regulus Therapeutics Inc.涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为1317.19%、824.65%、205.70%，振幅较大的相关个股有Azitra Inc、Briacell Therapeutics Corp C/Wts 24/02/2025、Invivyd, Inc.，振幅分别为49.48%、40.00%、29.25%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204225449a2392dcb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204225449a2392dcb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508141228","title":"Atyr Pharma, Inc.盘中异动 大幅跳水10.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508141228","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508141228?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:33","pubTimestamp":1738593209,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时33分，Atyr Pharma, Inc.股票出现波动，股价急速下跌10.69%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为341.63%、269.77%、129.47%，振幅较大的相关个股有Hcw Biologics Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Briacell Therapeutics Corp.，振幅分别为57.05%、33.33%、20.32%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223329abc1077a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223329abc1077a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508255962","title":"Atyr Pharma, Inc.盘中异动 大幅拉升5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508255962","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508255962?lang=zh_cn&edition=full","pubTime":"2025-02-01 00:21","pubTimestamp":1738340496,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日00时21分，Atyr Pharma, Inc.股票出现波动，股价快速上涨5.21%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.53%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd.、Silexion Therapeutics Corp较为活跃，换手率分别为2077.58%、1922.90%、172.02%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为71.20%、56.30%、52.24%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201002137a23556c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201002137a23556c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507621859","title":"Atyr Pharma, Inc.盘中异动 早盘股价大涨5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507621859","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507621859?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:39","pubTimestamp":1738247988,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时39分，Atyr Pharma, Inc.股票出现波动，股价急速拉升5.51%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Kazia Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Alterity Therapeutics Limited、Silexion Therapeutics Corp较为活跃，换手率分别为915.70%、137.07%、116.52%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Kazia Therapeutics Limited、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为56.41%、41.30%、28.90%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013022394896143e8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013022394896143e8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.atyrpharma.com","stockEarnings":[{"period":"1week","weight":-0.0763},{"period":"1month","weight":-0.139},{"period":"3month","weight":-0.0421},{"period":"6month","weight":-0.4642},{"period":"1year","weight":-0.9142},{"period":"ytd","weight":-0.4185}],"compareEarnings":[{"period":"1week","weight":-0.0036},{"period":"1month","weight":-0.0138},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1512},{"period":"1year","weight":0.1723},{"period":"ytd","weight":0.118}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"aTyr Pharma, Inc.于2005年9月8日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，专注于基于tRNA合成酶生物学开发治疗纤维化和炎症的疗法。其主要候选药物efzofitimod是一种新型免疫调节剂，正在研究用于治疗间质性肺病，包括肺结节病和系统性硬化症相关间质性肺病。","yearOnYearQuotes":[{"month":1,"riseRate":0.727273,"avgChangeRate":0.035951},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.011862},{"month":3,"riseRate":0.363636,"avgChangeRate":-0.068704},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.026181},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.082646},{"month":6,"riseRate":0.583333,"avgChangeRate":-0.008959},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.016959},{"month":8,"riseRate":0.25,"avgChangeRate":-0.046901},{"month":9,"riseRate":0.416667,"avgChangeRate":0.001096},{"month":10,"riseRate":0.363636,"avgChangeRate":0.029504},{"month":11,"riseRate":0.545455,"avgChangeRate":0.024303},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.061175}],"exchange":"NASDAQ","name":"ATYR PHARMA INC","nameEN":"ATYR PHARMA INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ATYR PHARMA INC(ATYR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ATYR PHARMA INC(ATYR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ATYR PHARMA INC,ATYR,ATYR PHARMA INC股票,ATYR PHARMA INC股票老虎,ATYR PHARMA INC股票老虎国际,ATYR PHARMA INC行情,ATYR PHARMA INC股票行情,ATYR PHARMA INC股价,ATYR PHARMA INC股市,ATYR PHARMA INC股票价格,ATYR PHARMA INC股票交易,ATYR PHARMA INC股票购买,ATYR PHARMA INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ATYR PHARMA INC(ATYR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ATYR PHARMA INC(ATYR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}